Biomarkers identification for PML monitoring, during Natalizumab (Tysabri ®) treatment in Relapsing-Remitting Multiple Sclerosis

This article review aims to list some biomarkers that have been proposed to evaluate the safety of natalizumab therapy.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research